Simultaneous measurement of specific serum IgG responses to five select agents

Analytical and Bioanalytical Chemistry

Volumn 382, Issue 4, 2005, Pages 1027-1034

  Biagini, R E ^a   Sammons, D L ^a   Smith, J P ^a   MacKenzie, B A ^a   Striley, C A F ^a   Robertson, S A ^a   Snawder, J E ^a   Quinn, C P ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Anthrax; Plague; Ricin; Staphylococcal enterotoxin B; Tularemia

Indexed keywords

ANTHRAX; PLAGUE; RICIN; STAPHYLOCOCCAL ENTEROTOXIN B; TULAREMIA;

ANTIBODIES; ANTIGENS; BIOASSAY; CONCENTRATION (PROCESS); EPIDEMIOLOGY; FLUORESCENCE; IMMUNOLOGY; PHYSIOLOGY; PROTEINS;

TOXIC MATERIALS;

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; IMMUNOGLOBULIN G; MICROSPHERE; RICIN;

ANIMAL; ANTIGEN ANTIBODY REACTION; ARTICLE; BACILLUS ANTHRACIS; COMPARATIVE STUDY; FLUOROIMMUNOASSAY; FRANCISELLA TULARENSIS; HUMAN; IMMUNOLOGY; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; ENTEROTOXINS; FLUOROIMMUNOASSAY; FRANCISELLA TULARENSIS; HUMANS; IMMUNOGLOBULIN G; MICROSPHERES; REPRODUCIBILITY OF RESULTS; RICIN; SENSITIVITY AND SPECIFICITY; YERSINIA PESTIS;

ANIMALIA; BACILLUS ANTHRACIS; FRANCISELLA TULARENSIS; STAPHYLOCOCCUS; YERSINIA PESTIS;

EID: 21244506234     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-005-3204-6     Document Type: Article

References (37)

1. DHHS (2002) Possession, use, and transfer of select agents and toxins; interim final role. Fed Regist 240(67):76866-76905
2. Biagini RE, Sammons DL, Smith JP, Page EH, Snawder JE, Striley CA, MacKenzie BA (2004) Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay. Occup Environ Med 61(8):703-708
3. Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Semenova V, Steward-Clark E, Stamey K, Freeman AE, Quinn CP et al (2004) Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immuno-globulin G antibodies to anthrax toxins. Clin Diagn Lab Immunol 11(1):50-55
4. Splettstoesser WD, Grunow R, Rahalison L, Brooks TJ, Chanteau S, Neubauer H (2003) Serodiagnosis of human plague by a combination of immunomagnetic separation and flow cytometry. Cytometry 53A(2):88-96
5. Splettstoesser WD, Rahalison L, Grunow R, Neubauer H, Chanteau S (2004) Evaluation of a standardized Fl capsular antigen capture ELISA test kit for the rapid diagnosis of plague. FEMS Immunol Med Microbiol 41(2):149-155
6. Thullier P, Guglielmo V, Rajerison M, Chanteau S (2003) Short report: Serodiagnosis of plague in humans and rats using a rapid test. Am J Trop Med Hyg 69(4):450-451
7. Valipour A, Koller H, Kreuzer A, Kossler W, Csokay A, Burghuber OC (2003) A case of primary tularemic pneumonia presenting with necrotizing mediastinal and hilar lymph nodes. Wien Klin Wochenschr 115(5-6):196-199
8. Maddaloni M, Cooke C, Wilkinson R, Stout AV, Eng L, Pincus SH (2004) Immunological characteristics associated with the protective efficacy of antibodies to ricin. J Immunol 172(10):6221-6228
9. Coffman JD, Zhu J, Roach JM, Bavari S, Ulrich RG, Giardina SL (2002) Production and purification of a recombinant Staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli. Protein Exp Purif 24(2):302-312
10. Swartz MN (2001) Recognition and management of anthrax - an update. N Engl J Med 345(22):1621-1626
11. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, McDade J, Osterholm MT, O'Toole T et al (1999) Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Jama 281(18):1735-1745
12. Pile JC, Malone JD, Eitzen EM, Friedlander AM (1998) Anthrax as a potential biological warfare agent. Arch Intern Med 158(5):429-434
13. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF et al (2000) Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Jama 283(17):2281-2290
14. Saslaw S, Eigelsbach HT, Wilson HE, Prior JA, Carhart S (1961) Tularemia vaccine study. I. Intracutaneous challenge. Arch Intern Med 107:689-701
15. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S (1961) Tularemia vaccine study II. Respiratory challenge. Arch Intern Med 107:702-714
16. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M et al (2001) Tularemia as a biological weapon: medical and public health management. Jama 285(21):2763-2773
17. Barbieri L, Baltelli M, Stirpe F (1993) Ribosomes-inactivating proteins from plants. Biochem Biophys Acta 1154:237-282
18. Ulrich R, Sidell S, Taylor T, Wilhelmsen C, Franz D (1997) Staphylococcal Enterotoxin B And Related Pyrogenic Toxins. In: Sidell F, Takafuji E, Franz D (eds) Medical aspects of chemical and biological warfare. Washington, DC: Office of The Surgeon General; pp 621-630
19. Semenova VA, Steward-Clark E, Stamey KL, Taylor TH Jr, Schmidt DS, Martin SK, Marano N, Quinn CP (2004) Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin Diagn Lab Immunol 11(5):919-923
20. Biagini RE, Schlottmann SA, Sammons DL, Smith JP, Snawder JC, Striley CA, MacKenzie BA, Weissman DN (2003) Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin Diagn Lab Immunol 10(5):744-750
21. Biagini RE, Smith JP, Sammons DL, MacKenzie B A, Striley CA, Robertson SK, Snawder JE (2004) Development of a sensitivity enhanced multiplexed fluorescence covalent micro-bead immunosorbent assay (FCMIA) for the measurement of glyphosate, atrazine and metolachlor mercapturate in water and urine. Anal Bioanal Chem 379(3):368-374
22. O'Connell M, Belanger B, Haaland P (1993) Calibration and assay development using the four-parameter logistic model. Chemom Intell Lab Syst 20:97-114
23. Nix B, Wild D (2001) Calibration curve-fitting. In: Wild D (ed) The immunoassay handbook. Nature Publishing Group, NY, pp 198-210
24. Jacobson RH (1998) Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech 17(2):469-526
25. Wasserman GM, Grabenstein JD, Pittman PR, Rubertone MV, Gibbs PP, Wang LZ, Golder LG (2003) Analysis of adverse events after anthrax immunization in US Army medical personnel. J Occup Environ Med 45(3):222-233
26. Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E et al (2002) Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 8(10):1103-1110
27. Quinn CP, Dull PM, Semenova V, Li H, Crotty S, Taylor TH, Steward-Clark E, Stamey KL, Schmidt DS, Stinson KW et al (2004) Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis 190(7):1228-1236
28. Porsch-Ozcurumez M, Kischel N, Priebe H, Splettstosser W, Finke EJ, Grunow R (2004) Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia. Clin Diagn Lab Immunol 11(6):1008-1015
29. Campbell DE, Kemp AS (1998) Production of antibodies to staphylococcal superantigens in atopic dermatitis. Arch Dis Child 79(5):400-404
30. Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine 22(31-32):4365-4373
31. Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES (2002) A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine 20(27-28):3422-3427
32. LeClaire RD, Bavari S (2001) Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob Agents Chemother 45(2):460-463
33. Waag DM, Sandstrom G, England MJ, Williams JC (1996) Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers. FEMS Immunol Med Microbiol 13(3):205-209
34. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M et al (2002) Investigation of bioterrorism-related anthrax. United States, 2001: epidemiologic findings. Emerg Infect Dis 8(10): 1019-1028
35. Pavlin JA (1999) Epidemiology of bioterrorism. Emerg Infect Dis 5(4):528-530
36. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, Crisanti A (2002) Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem 48(1):121-130
37. Bacarese-Hamilton T, Mezzasoma L, Ardizzoni A, Bistoni F, Crisanti A (2004) Serodiagnosis of infectious diseases with antigen microarrays. J Appl Microbiol 96(1):10-17